Lanreotide
Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, with higher affinity to peripheral receptors, and has similar activity.
Online Inquiry
| CAT# | R1812 |
| CAS | 108736-35-2, 127984-74-1 |
| Synonyms/Alias | Angiopeptin; Autogel; BIM-23014; BIM 23014; BIM23014; DC-13-116; Ipstyl; Somatuline; Lanreotidum; Lanreotida; Lanreotide; LS-153748; LS 153748; LS153748 |
| M.F/Formula | C54H69N11O10S2 |
| M.W/Mr. | 1096.33 |
| Sequence | Three Letter Code: H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bond) |
| Application | Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. |
| Areas of Interest | Acromegaly & Neuroendocrine tumors |
| Source# | Synthetic |
Storage | Desiccate at -20°C |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
Long-term Storage Conditions | −20°C |
Write a review
Ask a question
My Review for Lanreotide
Required fields are marked with *
×
Ask a Question for Lanreotide
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
